Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
Markets
/
Stocks
/
nasdaq-actu
/
Actuate Therapeutics Inc
ACTU
6.640
USD
-0.225
-3.28%
Close 09/19, 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
135.92M
Market Cap
Loss
P/E TTM
Actuate Therapeutics Inc
6.640
-0.225
-3.28%
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Analysis
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-56.11%
-4.17M
11.98%
-4.62M
--
-4.77M
--
-9.15M
--
-2.67M
2.08%
-5.25M
--
-5.36M
Net income from continuing operations
9.48%
-5.95M
23.86%
-6.32M
--
-6.45M
--
-5.97M
--
-6.57M
-57.41%
-8.30M
--
-5.27M
Other non-cash items
--
--
--
0.00
--
0.00
--
-343.24K
--
--
--
--
--
--
Change in working capital
-92.82%
191.31K
-75.95%
568.12K
--
482.09K
--
-4.32M
--
2.66M
1376.66%
2.36M
--
-185.07K
-Change in prepaid expenses
308.76%
163.26K
349.94%
207.12K
--
173.05K
--
-541.35K
--
-78.20K
-1679.92%
-82.87K
--
5.25K
-Change in other current assets
--
0.00
--
110.55K
--
-110.55K
--
--
--
--
--
--
--
--
-Change in other current liabilities
--
--
--
0.00
--
5.08K
--
13.56K
--
--
--
--
--
--
Cash from non-recurring investing activities
Cash from operating activities
-56.11%
-4.17M
11.98%
-4.62M
--
-4.77M
--
-9.15M
--
-2.67M
2.08%
-5.25M
--
-5.36M
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
608.12%
6.78M
-103.06%
-133.48K
--
-109.41K
--
22.32M
--
957.04K
76.88%
4.36M
--
2.46M
Net cash flow from debt Issuance/repayment
-100.00%
0.00
-100.00%
0.00
--
0.00
--
0.00
--
1.00M
--
4.50M
--
0.00
Net cash flow from common stock issuance/repurchase
--
2.16M
--
--
--
0.00
--
23.96M
--
--
--
--
--
--
Net cash flow from preferred stock issuance/repurchase
--
--
--
--
--
0.00
--
0.00
--
0.00
-100.00%
0.00
--
2.46M
Proceeds from stock option exercised by employees
--
34.12K
--
--
--
--
--
--
--
--
--
--
--
--
Net cash flow from other financing activities
10760.61%
4.58M
6.51%
-133.48K
--
-109.41K
--
-1.64M
--
-42.96K
--
-142.77K
--
0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
608.12%
6.78M
-103.06%
-133.48K
--
-109.41K
--
22.32M
--
957.04K
76.88%
4.36M
--
2.46M
Net cash flow
Beginning cash balance
88.05%
3.89M
192.08%
8.64M
--
13.52M
--
351.71K
--
2.07M
-85.53%
2.96M
--
20.45M
Current period cash flow changes
251.65%
2.60M
-433.75%
-4.75M
--
-4.88M
--
13.17M
--
-1.72M
69.25%
-890.35K
--
-2.90M
Ending cash balance
1746.03%
6.49M
88.05%
3.89M
--
8.64M
--
13.52M
--
351.71K
-88.22%
2.07M
--
17.55M
Currency unit
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up